Skip to main content
Show full summary

Baroness Ritchie of Downpatrick to ask His Majesty's Government what assessment they have made of the impact of access to cystic fibrosis transmembrane conductance regulator modulator therapies for people with cystic fibrosis on the ability of people with other respiratory conditions to receive lung transplants.  HL1290

Question HL1290: tabled on 18 December 2023 and due for answer by 4 January 2024

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Baroness Ritchie of Downpatrick to ask His Majesty's Government what assessment they have made of the impact of access to cystic fibrosis transmembrane conductance regulator modulator therapies for people with cystic fibrosis on the ability of people with other respiratory conditions to receive lung transplants.  HL1290
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.